The Anxiety- and Depression-like Behavioral Profile of Astrocytic FAK Knockout Mice
Location
Culp Ballroom
Start Date
4-7-2022 9:00 AM
End Date
4-7-2022 12:00 PM
Poster Number
2
Faculty Sponsor’s Department
Biomedical Sciences
Name of Project's Faculty Sponsor
Cuihong Jia
Additional Sponsors
Dr. Theo Hagg, Department of Biomedical Science, College of Medicine, East Tennessee State University
Competition Type
Competitive
Type
Poster Presentation
Project's Category
Biomedical Engineering
Abstract or Artist's Statement
The anxiety- and depression-like behavioral profile of Astrocytic FAK knockout mice
Steve Yang and Dr. Cuihong Jia, Department of Biomedical Sciences, College of Medicine, East Tennessee State University, Johnson City, TN.
Ciliary neurotrophic factor (CNTF) is expressed by astrocytes where it is believed to promote neurotransmitter synthesis and yet depression-like behaviors in mice, especially female mice based on our previous study. We have also discovered that inhibition of focal adhesion kinase (FAK) in astrocytes can upregulate CNTF. However, whether FAK inhibition-induced CNTF affects anxiety- or depression-like behaviors is still unclear. We, therefore, used Cre-lox system to upregulate CNTF expression in mice brains via selective and inducible knockout FAK in astrocytes. We then used behavioral tests, such as open field, elevated T-maze, sucrose swim, object location memory, to measure target mice's anxiety-like and depression-like behaviors. As a result of completing the behavior tests and by comparing to the control group, we learned that knockout of FAK in astrocytes did not affect anxiety – and depression-like behaviors in female mice, nor did it alter learning or memory abilities. Nevertheless, we found that FAK knockout in astrocytes of female mice seemed to increase their locomotor function. Further study will use the same procedures to expand on male mice, compare the results, and investigate the mechanism underlying the locomotor activities. We hope this work can be a useful tool in better understanding anxiety and mood disorders from a molecular level, especially posttraumatic stress disorder, and major depressive disorder so that more specific pharmacologic therapies can be developed to treat these illnesses.
The Anxiety- and Depression-like Behavioral Profile of Astrocytic FAK Knockout Mice
Culp Ballroom
The anxiety- and depression-like behavioral profile of Astrocytic FAK knockout mice
Steve Yang and Dr. Cuihong Jia, Department of Biomedical Sciences, College of Medicine, East Tennessee State University, Johnson City, TN.
Ciliary neurotrophic factor (CNTF) is expressed by astrocytes where it is believed to promote neurotransmitter synthesis and yet depression-like behaviors in mice, especially female mice based on our previous study. We have also discovered that inhibition of focal adhesion kinase (FAK) in astrocytes can upregulate CNTF. However, whether FAK inhibition-induced CNTF affects anxiety- or depression-like behaviors is still unclear. We, therefore, used Cre-lox system to upregulate CNTF expression in mice brains via selective and inducible knockout FAK in astrocytes. We then used behavioral tests, such as open field, elevated T-maze, sucrose swim, object location memory, to measure target mice's anxiety-like and depression-like behaviors. As a result of completing the behavior tests and by comparing to the control group, we learned that knockout of FAK in astrocytes did not affect anxiety – and depression-like behaviors in female mice, nor did it alter learning or memory abilities. Nevertheless, we found that FAK knockout in astrocytes of female mice seemed to increase their locomotor function. Further study will use the same procedures to expand on male mice, compare the results, and investigate the mechanism underlying the locomotor activities. We hope this work can be a useful tool in better understanding anxiety and mood disorders from a molecular level, especially posttraumatic stress disorder, and major depressive disorder so that more specific pharmacologic therapies can be developed to treat these illnesses.